MITOXANTRONE HCL

Formula & Concentration

MITOXANTRONE HCL – mitoxantrone 2 mg/mL concentrate,intravenous

Manufacturer

Meitheal Pharmaceuticals

Indications

follicular lymphoma; progressive diffuse large B-cell lymphoma; metastatic prostate carcinoma; secondary progressive multiple sclerosis; acute myeloid leukemia; conditioning prior to autologous stem cell transplant; relapsing form of multiple sclerosis

Product Options

Package Size

NDC #

Presentation

2 MG/ML

71288-0178-10

VIAL

2 MG/ML

71288-0179-13

VIAL

Shelf Life and Storage

Controlled Room Temp (20-25°C)